Meds & supplements › Pitavastatin
Medicine
Pitavastatin tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adult with primary hyperlipidemia.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Pitavastatin tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in:
The following serious adverse reactions are discussed in other sections of the labeling:
Pitavastatin tablets are contraindicated in the following conditions:
Table 2 includes a list of drugs that increase the risk of myopathy and rhabdomyolysis when administered concomitantly with pitavastatin tablets and instructions for preventing or managing drug interactions.
sofidex [Internet]. Daloreum; c2026. Pitavastatin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/pitavastatin
sofidex. (2026, August 3). Pitavastatin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/pitavastatin
Pitavastatin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/pitavastatin
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.